Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus
Akihiro Tamori, Kiyohide Kioka, Osamu Kurai, Hiroki Sakaguchi, Masaru Enomoto, Hideki Fujii, Sawako Kobayashi, Shuji Iwai, Hiroyasu Morikawa, Seiko Yamaguchi, Yasuko Kawasaki, Hiroko Oka, Yasuhito TanVolume:
41
Year:
2011
Language:
english
DOI:
10.1111/j.1872-034x.2011.00887.x
File:
PDF, 543 KB
english, 2011